Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $855 - $1,111
4 Added 0.08%
5,202 $1.22 Million
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $259 - $298
1 Added 0.02%
5,198 $1.37 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $543 - $628
-2 Reduced 0.04%
5,197 $1.63 Million
Q1 2021

May 13, 2021

BUY
$204.88 - $255.03 $8,195 - $10,201
40 Added 0.78%
5,199 $1.33 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $2,242 - $2,573
12 Added 0.23%
5,159 $1.05 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $70,152 - $84,546
-420 Reduced 7.54%
5,147 $969,000
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $113 - $182
1 Added 0.02%
5,567 $925,000
Q1 2020

May 14, 2020

BUY
$104.32 - $195.28 $104 - $195
1 Added 0.02%
5,566 $703,000
Q4 2019

Feb 13, 2020

SELL
$163.48 - $173.61 $8,827 - $9,374
-54 Reduced 0.96%
5,565 $941,000
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $201,103 - $241,195
-1,395 Reduced 19.89%
5,619 $972,000
Q1 2019

May 14, 2019

SELL
$123.7 - $156.3 $682,329 - $862,150
-5,516 Reduced 44.02%
7,014 $1.07 Million
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $234,874 - $338,430
-1,944 Reduced 13.43%
12,530 $1.58 Million
Q3 2018

Nov 13, 2018

SELL
$167.67 - $188.27 $10,730 - $12,049
-64 Reduced 0.44%
14,474 $2.51 Million
Q2 2018

Aug 13, 2018

SELL
$160.33 - $189.41 $64,132 - $75,764
-400 Reduced 2.68%
14,538 $2.61 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $2.41 Million - $2.66 Million
14,938 New
14,938 $2.42 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Ativo Capital Management LLC Portfolio

Follow Ativo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ativo Capital Management LLC with notifications on news.